Translational Stroke Research covers basic, translational, and clinical studies. The Journal emphasizes novel approaches in order to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment, and repair after stroke and other forms of neurotrauma.
Translational Stroke Research focuses on translational research and is relevant to both basic scientists and physicians, including but not restricted to neuroscientists, vascular biologists, neurologists, neuroimagers, and neurosurgeons. The Journal provides an interactive forum for the dissemination of original research articles, review articles, research reports, letters, comments, and research protocols, in stroke and stroke related areas. Its distinguished editorial board is made up of leading stroke researchers and physicians from North America, Europe, and Asia.
Why publish with us
- As a journal ranked in the top quartile worldwide for both Neuroscience and Clinical Neurology, we are uniquely focused on the translational aspect of stroke research, ensuring its relevance to both basic scientists and physicians.
- Our committed editorial team oversees a rigorous yet swift review process, averaging 26 days from submission to first decision.
- We provide high levels of author satisfaction, with 89% of our published authors reporting that they are likely to publish with us again.
- John H Zhang
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
- 5.780 (2019)
- Impact factor
- 5.003 (2019)
- Five year impact factor
- 26 days
- Submission to first decision
- 126 days
- Submission to acceptance
- 87,589 (2019)
Authors (first, second and last of 14)
The Key Regulator of Necroptosis, RIP1 Kinase, Contributes to the Formation of Astrogliosis and Glial Scar in Ischemic Stroke
Authors (first, second and last of 12)
Neurovascular Units and Neural-Glia Networks in Intracerebral Hemorrhage: from Mechanisms to Translation
Authors (first, second and last of 7)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- OCLC WorldCat Discovery Service
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)